Form 4: Apyx Medical Executive Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Moshe Citronowicz, Sr. V.P. of Operations at Apyx Medical, was granted 63,392 stock options exercisable at $4.65 per share.
Summary
- Moshe Citronowicz, Senior Vice President of Operations at Apyx Medical Corporation, received a grant of 63,392 stock options.
- The options have an exercise price of $4.65 per share.
- The grant date for these options is June 11, 2026.
- The options are set to expire on June 11, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- The grant aligns the interests of the Senior Vice President of Operations with long-term shareholder value through equity-based compensation.
Negatives
- The issuance of new stock options results in potential future dilution for existing shareholders upon exercise.
Risks
- The value of the granted options is dependent on the future market performance of Apyx Medical common stock exceeding the $4.65 strike price.
Future Outlook
The options vest ratably over a thirty-six month period, becoming fully exercisable on the third anniversary of the grant date, June 11, 2029.
Management Comments
- No specific management commentary was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that equity grants to key operational executives are standard practice in the medical device sector to ensure retention and incentivize operational efficiency.
Comparison to Industry Standards
- The vesting schedule of 36 months is consistent with standard corporate governance practices for executive equity compensation in the mid-cap medical technology sector.
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of options will occur ratably over the next 36 months.
Key Dates
| Date | Description |
|---|---|
| 06/11/2026 | Date of grant for stock options and earliest transaction date. |
| 06/15/2026 | Date of filing. |
| 06/11/2036 | Expiration date of the granted stock options. |
Keywords
Apyx Medical, APYX, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.